- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Gotham Asset Management Boosts Stake in Johnson & Johnson
Investment firm increases holdings in pharmaceutical giant by 15.6% in Q3
Mar. 16, 2026 at 10:39am
Got story updates? Submit your updates here. ›
Gotham Asset Management LLC, an investment management firm, has increased its holdings in Johnson & Johnson (NYSE: JNJ) by 15.6% during the third quarter of 2025, according to a recent SEC filing. The firm now owns 213,036 shares of the company's stock, valued at $39,501,000.
Why it matters
Johnson & Johnson is a major pharmaceutical and consumer healthcare company, and changes in institutional ownership can signal broader market sentiment about the company's performance and future prospects. Gotham Asset Management's increased stake suggests the firm sees value in JNJ's stock at current levels.
The details
Gotham Asset Management, a New York-based investment management firm, disclosed in a 13F filing that it boosted its position in Johnson & Johnson by 28,690 shares during the third quarter of 2025. This represents a 15.6% increase in the firm's holdings of the healthcare giant's stock.
- Gotham Asset Management increased its Johnson & Johnson holdings during the 3rd quarter of 2025.
The players
Gotham Asset Management LLC
A New York-based investment management firm that focuses on long/short equity strategies.
Johnson & Johnson
A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.
The takeaway
Gotham Asset Management's increased stake in Johnson & Johnson suggests the firm sees continued growth potential in the pharmaceutical giant's stock, even as the broader market faces economic uncertainty.


